CXCR5 and COVID-19: Comparing COVID-19 and controls at the level of MFI for each subject within each MC and each subset revealed expression patterns highly comparable to CAP, such as decreased HLA-DR and CD11c, and increased PD-L1, PD-1, CD95/Fas, CD38 and CXCR5 (Figures 6C, D).